DH endorses recall of tablet for relief of allergic symptoms

Hong Kong (HKSAR) -      The Department of Health (DH) today (December 1) endorsed a licensed drug wholesaler, Kai Yuen Pharmaceutical Company (Kai Yuen), to recall a batch (Lot No./ Mfg. Lot No.: C18) of Finska Tablet 10mg (registration number HK-57988) from the market due to quality issue.

     During the DH's market surveillance, samples of the above product were collected for analysis and examination. Upon testing by the Public Health Laboratory Services Branch of the Centre for Health Protection, samples of the product were found to have exceeded the pharmacopoeial requirements on bacterial counts.

Kai Yuen voluntarily recalls the above batch from the market. The DH's investigation is continuing.

     Finska Tablet 10mg contains loratadine, which is a Part 1 poison under the Pharmacy and Poisons Ordinance (Cap 138) and is used for the relief of allergic symptoms. According to the wholesaler, the affected batch has been supplied to private doctors, local pharmacies and other wholesaler.

     "So far, the DH has not received any adverse drug reaction reports in connection with the product. We will closely monitor the recall," a spokesman for the DH said.

     "Members of the public should consult healthcare professionals if in doubt or feeling unwell after using the product," the spokesman added.

     Kai Yuen has set up a hotline (2395 5763) to answer related enquiries.

Published on: 2017-12-01

Limited copyright is granted for you to use and/or republish any story on this site for any legitimate media purpose as long as you reference 7thSpace and any source mentioned in the story above. Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.


Custom Search


© 2018 7thSpace Interactive
All Rights Reserved - About | Disclaimer | Helpdesk